Originally published on Mon March 25, 2013 8:49 am
The calendar says one thing, but the snow, slush and ice coating the nation from the Central Rockies through parts of the Midwest and on into the mid-Atlantic and Northeast say something else entirely.
Originally published on Mon March 25, 2013 7:34 am
RENEE MONTAGNE, HOST:
And police in Britain are piecing together the final days in the life of a Russian oligarch named Boris Berezovsky. They hope this may shed light on his sudden death this last weekend. Berezovsky used to be one of the wealthiest and most powerful men in Russia. Then he fell out with the Kremlin and sought asylum in Britain. NPR's Philip Reeves reports.
Despite the enormous destruction Hurricane Sandy caused to the Jersey Shore, realtors who specialize in the region say business has been steady. Plenty of home buyers and investors appear eager to jump into the market. Damaged homes and lots have been selling for discounted rates, while prices are inching up on houses that survived since there are simply fewer properties available.
Both housing and the stock market have been on the upswing in recent months. But a full recovery in the housing market would be more significant to the overall economy. That's because more Americans have something at stake in home values than in stock prices.
As far back as he can remember, George McCann lived in fear. When he was asleep he would have horrific nightmares filled with violent images. When he was awake, he often felt threatened by people, including members of his own family. And when he felt threatened, he would become aggressive, even violent.
George spent his childhood certain that something very bad was going to happen. And when he was 12, it did. His unrelenting fears led to a violent outburst at school. And George landed in a psychiatric hospital.
The U.S. Supreme Court hears arguments Monday in a case worth billions of dollars to pharmaceutical companies and American consumers. The issue is whether brand-name drug manufacturers may pay generic drug manufacturers to keep generics off the market. These payments — a form of settlement in patent litigation — began to blossom about a decade ago when the courts, for the first time, appeared to bless them.